drugset / Trial / NCT05077475
A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52L in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
To evaluate the safety and pharmacokinetic characteristics of AJU-C52L in healthy adults
Timeline
- Start
- 2021-09-24
- Primary completion
- 2022-04-30
- Completion
- 2022-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | Oral |
| Subject | Amlodipine | Other / unclassified | 10 mg | Oral |
| Subject | Chlorthalidone | Other / unclassified | 12.5 mg | Oral |
| Subject | Chlorthalidone | Other / unclassified | 25 mg | Oral |
| Subject | Valsartan | Small molecule | 80 mg | Oral |
| Subject | Valsartan | Small molecule | 160 mg | Oral |